Closed · W81XWH-10-NFRP-IIFRA · CFDA 12.420 · Discretionary

DoD Neurofibromatosis Investigator-Initiated Focused Research Award

Federal grant opportunity posted by Defense Health Agency Contracting Activity - DHACA, cataloged on Grants.gov.

Varies
Award range
Closed
Status
May 20, 2010
Close date
3
Expected awards

The verdict

DoD Neurofibromatosis Investigator-Initiated Focused Research Award is a closed discretionary listing from Defense Health Agency Contracting Activity - DHACA that offered Varies by applicant across 3 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,795 other opportunities from Defense Health Agency Contracting Activity - DHACA.

Varies
award range
Closed
application status
3
expected awards
12.420
CFDA program

Archived opportunity record

DoD Neurofibromatosis Investigator-Initiated… is closed (last close May 20, 2010). Check the agency catalog for replacement NOFOs. Defense Health Agency Contracting Activity - DHACA still indexes 1,795 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed May 20, 2010

Posted Feb 23 Closes May 20

Est. Total Funding

$3,000,000

Expected Awards

3

Instrument

Grant

Description

The NFRP Investigator-Initiated Focused Research Award (IIFRA) mechanism is being offered for the first time in FY10. Research Focus Areas: Proposals for this mechanism must address one or more of the following areas related to NF and/or Schwannomatosis: • Pain • Wound repair • Nerve regeneration • Stress and inflammation • Cognitive dysfunction • Health-related quality of life • Neurofibromin protein Research involving participation of human subject use is permitted; however, clinical trials are NOT ALLOWED under this funding opportunity. In general, a clinical trial is defined as a prospective study where an intervention (e.g., device, drug, behavioral, surgical procedure, or other) is tested on human subjects for a measurable outcome. Principal Investigators (PIs) wishing to apply for funding for a clinical trial should utilize the Clinical Trial Award mechanism. Refer to the General Application Instructions, Appendix 5, for additional information about studies involving human subjects, human subjects data, or human anatomical substances. Applications must include preliminary data originating from the PI, research team, or collaborator that is relevant to NF and the proposed project. Optional Qualified Collaborator(s): The FY10 NFRP strongly encourages collaborative research between basic scientists and clinical researchers, and between academic scientists and biotechnology/pharmaceutical industry scientists. Collaborations that bring new perspectives from other disciplines or bring new investigators into the NF field are also strongly encouraged. Collaborations that meet the criteria below will qualify for a higher level of funding as described in Section I.D. For the application to qualify for the higher level of funding, the PI must submit a Statement of Collaboration that clearly identifies the collaborating investigator and addresses how each of the criteria below are met. Additionally, the collaborator must provide a letter of collaboration describing his/her involvement in the proposed work. It should be clear that the success of the project depends on the unique skills and contributions of each partner. • The collaborator(s) must significantly contribute to the project such that the proposed work could not be accomplished without his/her involvement. ○ A proposed project in which the collaborator(s) merely supplies tissue samples or access to patients will not meet the intent and will not be qualified for the higher level of funding. • The collaborator(s) must be at or above the level of Assistant Professor (or equivalent). • At least a 10% level of effort is required of the collaborator(s). Contribution of the collaborator should be reflected in the application’s budget.

Catch-all / unrestricted eligibility mark · W81XWH-10-NFRP-IIFRA

Grants.gov marks DoD Neurofibromatosis Investigator-Initiated… with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the Defense Health Agency Contracting Activity - DHACA book (1,791 peers, 100% of 1,796).

Code 99
Unrestricted / see official listing

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org

What to do next

DoD Neurofibromatosis Investigator-Initiated… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 12.420 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants